Cidara Therapeutics, Inc.

Go to Cidara Therapeutics, Inc. Website

$61.77

0.00 (0.00%)
Live
Previous Close

$61.77

Day Range

$0 - $0

Previous Day Range

$59.64 - $62.845

Market Cap

$1.4 billion USD

Day Vol.

0

Previous Day Vol.

326187

Currency

USD

Primary Exchange

Nasdaq

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprise...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Cidara Therapeutics granted non-qualified stock options and restricted stock units totaling 12,100 shares to two new employees under its 2020 Inducement Incentive Plan, with stock options priced at $48.71 per share and vesting over four years.

Related tickers: CDTX.

Read Full Article

Cidara Therapeutics announced the pricing of an underwritten public offering of 7,954,546 shares of its common stock at a price of $44.00 per share, raising $350 million in gross proceeds.

Related tickers: CDTX.

Read Full Article
Trending Tickers

Please sign in to view